Search
Marker Therapeutics Inc
MRKRAdd to Watchlist
1.220USD
-0.050-3.94%
Close 07-24 16:00（ET）Quotes delayed by 15 min
20.34MMarket Cap
LossP/E TTM
MRKR Income Statement
You can find the annual or quarterly income statement of Marker Therapeutics Inc here for insights into the performance and operational efficiency of Marker Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
How do I read Marker Therapeutics Inc's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing MRKR stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Marker Therapeutics Inc's revenue at year end?
Marker Therapeutics Inc reported 3.55M in revenue for fiscal year 2025, up from 6.59M in the previous year.
How much revenue did Marker Therapeutics Inc report in the most recent quarter?
Marker Therapeutics Inc reported 751.69K in revenue for the most recent quarter, an increase of 115.32% year over year.
What was Marker Therapeutics Inc's net income for the year?
Marker Therapeutics Inc posted -12.16M in net income for fiscal year 2025.
How much net income did Marker Therapeutics Inc post in the last quarter?
Marker Therapeutics Inc reported -3.18M in net income for the latest quarter。
What was Marker Therapeutics Inc's annual operating profit?
Marker Therapeutics Inc's operating income was -12.44M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.